Hyppigheden af MCyR efter to år var ens for patienter med BCR- ABL- mutation, P- loop- mutation eller ingen mutation ved baseline (henholdsvis 63%, 61% og 62%).
The rates of MCyR at 2 years were similar whether patients had any baseline BCR-ABL mutation, P-loop mutation, or no mutation (63%, 61% and 62%, respectively).